Prevalencia de Alteraciones del Metabolismo de la Glucosa y su Relación con Factores de Riesgo para Diabetes en Huicholes con Estilo de Vida Urbano

P Aguiar-García; A Flores-García; JM Miramontes-Carrillo; F Espinoza-Gómez; A Michel-Rosales; M Ramírez-Rangel; R Sánchez-Gutiérrez; S Ruiz-Bernés

2016, Number 14

waxapa 2016; 8 (14)

Prevalencia de Alteraciones del Metabolismo de la Glucosa y su Relación con Factores de Riesgo para Diabetes en Huicholes con Estilo de Vida Urbano

Aguiar-García P, Flores-García A, Miramontes-Carrillo JM, Espinoza-Gómez F, Michel-Rosales A, Ramírez-Rangel M, Sánchez-Gutiérrez R, Ruiz-Bernés S

Full text

How to cite this article

Language: Spanish
References: 21
Page: 21-27
PDF size: 0. Kb.

ABSTRACT

Background. The exposition of ethnic groups to an urban environment has impacted the rates of obesity and diabetes.
Objective. Assess the prevalence of abnormal glucose metabolism (AGM) and its relationship with risk factors for diabetes (RFD) in Huichol people with styles of rural and urban life.
Methods. A transversal study was performed convenience type two Huichol indigenous groups were formed; Group 1, 100 participants of communities from Nayar and La Yesca, state of nayarit, Group 2, 100 participants from city of Tepic, Nayarit, Mexico, with one year or more of residence. The participants determined; fasting glucose and 2-hour post-load, anthropometric measurements, levels of caloric intake and physical activity. The variables using logistic regression test were analyzed, to determine the relationship with RFD.
Results. AGM prevalence was higher in Group 2 vs Group 1, although no significant difference was found, except in impaired fasting glucose (IFG) (p‹ 0.05). Elevated body mass index (BMI) was the most RFD related to AGM (p ‹ 0.0001).
Conclusions. The prevalence of the AGM in Group 2 showed a non-significant increase vs Group 1, except for the IFG which was a significant increase in the exposed group, also showed elevated BMI as the most correlated RFD with the AGM, which may represent a risk for this ethnic group of developing T2DM in the coming years.

REFERENCES

Carter JS, Pugh JA, Monterrosa A. Non-Insulin-Dependent Diabetes Mellitus in Mínorities in the United States. Annals of Internal Medicine. 1996;125 (3): 221-232.
Franks PW, Pearson E, Florez JC. Gene-Environment and Gene-Treatment in Type 2 Diabetes. Diabetes Care, volume 36. 2013: 1413 – 1421.
Ujcic-Voortman JK, Schram MT, Jacobs-van der Bruggen ME, Verhoeff AP, Baan CA. Diabetes prevalence and risk factors among ethnic minorities. European Journal of Public Health, 2009; Vol. 19: No. 5, 511–515.
Pacheco L. de G. Etnias de Nayarit. UAN. Tepic, Nayarit; 1998.
Luboshitzky R, Atar S, Qupti G, Tamir A, Dgani M, and Glatau E. Prevalence of diabetes mellitus and glucose intolerance in adult Ethiopian inmigrants. Harefuah. JIDM 1995; 128(7):406-8.
ADA. Screening, for Type 2 Diabetes. 2003. 21(1): S20-S22.
Encuesta Nacional de salud y Nutrición. Instituto Nacional de Salud. Cuernavaca, México, 2007.
James S, Jamjoum L, Raghunathan T, Strogatz D, Furth E y Khazanie P. Physical Activity and NIDDM in African-Americans. Diabetes Care. 1998; 21(4) :555-562.
Bock G, Man CD, Campioni M, Chittilapilly E, Basu R. Toffolo G, et al. Mechanisms of Fasting and Postprandial Hyperglycemia in People With Impaired Fasting Glucose and/or Impaired Glucose Tolerance. Diabetes, VOL. 55. 2006.
Sobngwi E, Mbaaya JC, Kenye AP, Fezeu L, Aspray TJ, Alberti K. Int. J. of Epidemiology 2004; 4: 769-776.
Schulz LO, Bennett PH, Ravussin E, et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 2006;29:15866–1871.
12 Bonnefond A, Froguel P, Vaxillaire M. The emerging genetics of type 2 diabetes. Trends in Molecular Medicine 2010;16:407-416
Lebovitz HE. Type 2 diabetes: the evolution of a disease. The British Journal of Diabetes and Vascular Disease volume 2 issue 6. 2012.
Meigs JB, Wilson PT, Fox CS, Vasan RS, Nathan DM et al. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease. J Clin Endocrinol Metab 2006; 91: 2906 2912.
Olaiz G, Rivera J, Shamah T, Rojas R, Villalpando S, Hernandez M, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca (México): Instituto Nacional de Salud Pública; 2006.
Flores M, Macias N, Rivera M, Lozada A, Barquera S, Rivera-Dommarco J, et al. Dietary Patterns in Mexican Adults Are Associated with Risk of Being Overweight or Obese. J. Nutr. 140: 1869–1873, 2010.
Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood D, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011; 378: 804–14
Grundy SM. Metabolic Syndrome Pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology 2008; 828:629.
Rippe JM, and Angelopoulos TJ. Physical Activity and Health: The Time for Action Is Now.American Journal of Lifestyle Medicine 2010 4: 205
US Department of Health and Human Services. Physical Activity Guidelines Advisory. Committee Report 2008. Washington, DC: US Department of Health and Human Services; 2008
Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity. International Journal of Obesity 2010; 34, 791-799.